Study of Latinos (SOL) Ojos

拉丁裔研究 (SOL) 奥霍斯

基本信息

  • 批准号:
    10471195
  • 负责人:
  • 金额:
    $ 231.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-09-01 至 2024-07-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT This application proposes an ancillary eye study to the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). HCHS/SOL is a prospective, population-based, multicenter cohort, funded by the National Heart, Lung, and Blood Institute (NHLBI) and 6 other National Institutes of Health (NIH) Institutes, that is designed to 1) assess disease burden; and, 2) address cardiovascular disease (CVD), stroke, asthma, chronic obstructive pulmonary disease, sleep disorders, dental caries and periodontal disease, hearing impairment, diabetes, kidney and liver disease, and cognitive impairment. This landmark study, the largest ever conducted in Hispanics/Latinos, constitutes a national resource of extensive, high-quality phenotypic and genotypic data. Participants include those of Mexican, Cuban, Dominican, Puerto Rican, Central and South American, and Other origins. HSHC/SOL recruited 16,415 participants for Visit #1 (2008-2011); data collection for Visit #2 (2014-2017) concluded 12/17 (Chicago and Miami Field Centers: 82.3% participation rate); and, NHLBI contracted HCHS/SOL Visit #3 (2019-2022) funding to serve as a platform for ancillary studies. We will recruit and perfom a detailed eye exam on 2500 HCHS/SOL participants from Chicago and Miami aged ≥40 years to coincide with Visit #3. The HCHS/SOL Coordinating Center will provide direction in oversampling older adults to maximize disease detection efficiency, with sampling weights reflecting probabilities of selection to maintain accurate prevalence rates. Latinos of diverse backgrounds as in HCHS/SOL represent a rich sociocultural and genetically admixed group, inheriting a mixture of European, Native American, and African ancestry from populations previously isolated. As such, the HCHS/SOL Eye Study will represent the first highly admixed eye epidemiology cohort. This heterogeneity and intrinsic variability, essential in basic and clinical research, innovatively positions the HCHS/SOL Eye Study to assess important etiologic pathways amid prevalent risk factors and outcomes that cannot be assessed with homogenous cohorts. We propose to collect high-quality eye outcome data, identical to National Eye Institute (NEI)-funded population-based cohorts, which will allow the eye epidemiology community to, for the first time, assess novel hypotheses associated with systemic disease in a well-characterized, diverse cohort. The HCHS/SOL Eye Study is designed to 1) assess and compare the 2010 age-standardized prevalence of chronic eye disease across Hispanic/Latino groups using previously constructed HCHS/SOL “genetic analysis groups” (Mainland: Mexicans, Central and South Americans; and, Caribbean: Cubans, Dominicans, and Puerto Ricans); and, 2) assess whether prevalent disease is associated with novel CVD, biomedical, and sociocultural risk factors. Proposed research leverages NHLBI-funded epidemiologic research supported by 6 other NIH Institutes, and represents a significant opportunity for highly innovative and efficient epidemiologic eye research.
项目总结/摘要 本申请为西班牙裔社区健康研究/拉丁裔研究提出了一项辅助眼科研究 (HCHS/SOL)。HCHS/SOL是一项前瞻性的、基于人群的、多中心队列研究,由国家心脏基金会资助, 肺和血液研究所(NHLBI)和其他6个国立卫生研究院(NIH)研究所,旨在 1)评估疾病负担; 2)解决心血管疾病(CVD)、中风、哮喘、慢性阻塞性肺疾病(COPD) 肺病、睡眠障碍、龋齿和牙周病、听力障碍、糖尿病, 肾脏和肝脏疾病以及认知障碍。这项具有里程碑意义的研究,是有史以来规模最大的一次, 西班牙裔/拉丁美洲人,构成了广泛的,高质量的表型和基因型数据的国家资源。 与会者包括墨西哥人、古巴人、多米尼加人、波多黎各人、中美洲和南美洲人, 其他起源。HSHC/SOL招募了16,415名参与者进行访视#1(2008-2011);访视#2的数据收集 (2014-2017)完成12/17(芝加哥和迈阿密现场中心:82.3%的参与率);以及,NHLBI 合同HCHS/SOL访问#3(2019-2022)资金作为辅助研究的平台。我们将招募 对来自芝加哥和迈阿密的2500名年龄≥40岁的HCHS/SOL参与者进行详细的眼科检查, 与访视#3一致。HCHS/SOL协调中心将为老年人的过度抽样提供指导 最大限度地提高疾病检测效率,抽样权重反映选择的概率,以保持 准确的流行率。在HCHS/SOL不同背景的拉丁美洲人代表了丰富的社会文化, 基因混合组,继承了欧洲,美洲土著和非洲血统的混合物, 以前被隔离的人群。因此,HCHS/SOL眼科研究将代表第一只高度混合的眼睛。 流行病学队列这种异质性和内在变异性在基础和临床研究中至关重要, 创新性地将HCHS/SOL眼科研究定位为在普遍风险中评估重要的病因途径 不能用同质队列评估的因素和结果。我们建议收集高质量的 眼睛结果数据,与国家眼科研究所(NEI)资助的基于人群的队列相同,这将允许 眼流行病学界,第一次,评估新的假设与系统性 疾病在一个良好的特征,多样化的队列。HCHS/SOL眼科研究旨在1)评估和 比较2010年西班牙裔/拉丁裔群体慢性眼病的年龄标准化患病率 使用先前构建的HCHS/SOL“遗传分析组”(大陆:墨西哥人、中部和 南美洲人;和,加勒比:古巴人,多米尼加人,和波多黎各人);和,2)评估是否 流行性疾病与新的CVD、生物医学和社会文化风险因素相关。提出 这项研究利用了NHLBI资助的流行病学研究,该研究得到了其他6个NIH研究所的支持, 这是高度创新和高效的流行病学眼科研究的重要机会。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHARLOTTE E JOSLIN其他文献

CHARLOTTE E JOSLIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHARLOTTE E JOSLIN', 18)}}的其他基金

Study of Latinos (SOL) Ojos
拉丁裔研究 (SOL) 奥霍斯
  • 批准号:
    10682630
  • 财政年份:
    2019
  • 资助金额:
    $ 231.96万
  • 项目类别:
Study of Latinos (SOL) Ojos
拉丁裔研究 (SOL) 奥霍斯
  • 批准号:
    9790099
  • 财政年份:
    2019
  • 资助金额:
    $ 231.96万
  • 项目类别:
Study of Latinos (SOL) Ojos
拉丁裔研究 (SOL) 奥霍斯
  • 批准号:
    10004657
  • 财政年份:
    2019
  • 资助金额:
    $ 231.96万
  • 项目类别:
Study of Latinos (SOL) Ojos
拉丁裔研究 (SOL) 奥霍斯
  • 批准号:
    10232086
  • 财政年份:
    2019
  • 资助金额:
    $ 231.96万
  • 项目类别:
Corneal Refractive Power Post Refractive Surgery
屈光手术后的角膜屈光力
  • 批准号:
    6946775
  • 财政年份:
    2004
  • 资助金额:
    $ 231.96万
  • 项目类别:
Corneal Refractive Power Post Refractive Surgery
屈光手术后的角膜屈光力
  • 批准号:
    6806743
  • 财政年份:
    2004
  • 资助金额:
    $ 231.96万
  • 项目类别:
Corneal Refractive Power Post Refractive Surgery
屈光手术后的角膜屈光力
  • 批准号:
    7484147
  • 财政年份:
    2004
  • 资助金额:
    $ 231.96万
  • 项目类别:
Corneal Refractive Power Post Refractive Surgery
屈光手术后的角膜屈光力
  • 批准号:
    7118936
  • 财政年份:
    2004
  • 资助金额:
    $ 231.96万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 231.96万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 231.96万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 231.96万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 231.96万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 231.96万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 231.96万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 231.96万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 231.96万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 231.96万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 231.96万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了